Diagnostic value of diffusion tensor imaging and positron emission tomography in early stages of frontotemporal dementia

Manuscript Number: 

17-0224R3

Author(s): 
Thomas Duning, Andreas Johnen, Julia Krämer, Gero Lueg, Sven G. Meuth, Matthias Pawlowski, Patrick Schiffler, Anja Teuber, Alexis Vrachimis, Matthias Weckesser, Christian Wenning, Heike Wersching

Disclosures

Thomas Duning

  • Nothing to Disclose

Andreas Johnen

  • Lecture Fees:
    Travel expenses and lecture fees from Actelion Pharmaceuticals.

Julia Krämer

  • Lecture Fees:
    Dr. Julia Krämer received honoraria for lecturing from Novartis, Biogen, and TEVA.
    Grants
    • Agency: 
      Research Proposal Genzyme
      Dates: 
      2016 - 2017
    • Agency: 
      Research Proposal Novartis
      Dates: 
      2017 - 2018

Gero Lueg

  • Nothing to Disclose

Sven G. Meuth

  • Lecture Fees:
    Sven Meuth has received honoraria for lecturing, travel expenses for attending meetings and financial research support from Almirall, Bayer Health Care, Biogen, Diamed, Genzyme, MedDay Pharmaceuticals, Merck Serono, Novartis, Novo Nordisk, ONO Pharma, Roche, Sanofi-Aventis, Chugai Pharma, QuintilesIMS and Teva.
    Patents/Royalties
    Sven Meuth has received honoraria for lecturing, travel expenses for attending meetings and financial research support from Almirall, Bayer Health Care, Biogen, Diamed, Genzyme, MedDay Pharmaceuticals, Merck Serono, Novartis, Novo Nordisk, ONO Pharma, Roche, Sanofi-Aventis, Chugai Pharma, QuintilesIMS and Teva.

Matthias Pawlowski

  • Nothing to Disclose

Patrick Schiffler

  • Nothing to Disclose

Anja Teuber

  • Nothing to Disclose

Alexis Vrachimis

  • Nothing to Disclose

Matthias Weckesser

  • Nothing to Disclose

Christian Wenning

  • Nothing to Disclose

Heike Wersching

  • Nothing to Disclose